Accedi

Bibliografie tematiche / Disease prevention / Articoli di riviste

Segui questo link per vedere altri tipi di pubblicazioni sul tema: Disease prevention.

Articoli di riviste sul tema "Disease prevention"

Autore: Grafiati

Pubblicato: 4 giugno 2021

Ultima modifica: 29 luglio 2024

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili

Scegli il tipo di fonte:

Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Disease prevention".

Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.

Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.

Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.

1

Shakhnoza, Iskandarova, e Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE". American Journal of Medical Sciences and Pharmaceutical Research 04, n. 04 (1 aprile 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Testo completo

Abstract (sommario):

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

Gli stili APA, Harvard, Vancouver, ISO e altri

2

&NA;. "DISEASE PREVENTION". American Journal of Nursing 99, n. 8 (agosto 1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Pignone, Michael P., e Kirsten Bibbins-Domingo. "Disease Prevention". Medical Clinics of North America 101, n. 4 (luglio 2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Shubrook, Jay H. "Disease prevention". Osteopathic Family Physician 3, n. 5 (settembre 2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Selby, JoeV. "DISEASE PREVENTION". Lancet 341, n. 8847 (marzo 1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

SCHAPIRA, DAVID V. "Disease Prevention". Archives of Internal Medicine 149, n. 6 (1 giugno 1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention". Learning & Education 9, n. 2 (10 novembre 2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Testo completo

Abstract (sommario):

Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many developed countries already have rich experience in the prevention and treatment of various occupational diseases. They have set up various occupational disease prevention agencies and formulated strict occupational disease prevention systems. It is necessary for developing countries to learn from their advanced control measures.

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova e Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION". UZBEK MEDICAL JOURNAL 2, n. 2 (28 febbraio 2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Testo completo

Abstract (sommario):

Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease". Women Health Care and Issues 2, n. 2 (10 dicembre 2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Testo completo

Abstract (sommario):

Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich e Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases". American Journal of Medical Sciences and Pharmaceutical Research 03, n. 06 (10 giugno 2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Testo completo

Abstract (sommario):

Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiovascular disease.2 This article analyzes the prevention and treatment of cardiovascular diseases, and has obtained a series of practical and reliable conclusions.

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Pipe, Andrew. "Cardiovascular disease prevention". Current Opinion in Cardiology 33, n. 5 (settembre 2018): 498–99. http://dx.doi.org/10.1097/hco.0000000000000551.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Van Camp, G. "Cardiovascular disease prevention". Acta Clinica Belgica 69, n. 6 (31 agosto 2014): 407–11. http://dx.doi.org/10.1179/2295333714y.0000000069.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Schargrodsky, Herman, María C. Escobar e Edgardo Escobar. "Cardiovascular Disease Prevention". Circulation 98, n. 20 (17 novembre 1998): 2103–4. http://dx.doi.org/10.1161/01.cir.98.20.2103.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Rendall, G. "Bee disease prevention". Veterinary Record 122, n. 13 (26 marzo 1988): 311–12. http://dx.doi.org/10.1136/vr.122.13.311.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Kapustin, Jane. "Chronic Disease Prevention". Journal for Nurse Practitioners 6, n. 1 (gennaio 2010): 6. http://dx.doi.org/10.1016/j.nurpra.2009.09.017.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Keevil, Jon G., James H. Stein e Patrick E. McBride. "Cardiovascular disease prevention". Primary Care: Clinics in Office Practice 29, n. 3 (settembre 2002): 667–96. http://dx.doi.org/10.1016/s0095-4543(02)00012-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Burns, Jackie. "Pneumococcal disease prevention". Primary Health Care 12, n. 8 (ottobre 2002): 24–26. http://dx.doi.org/10.7748/phc.12.8.24.s21.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

Dietz, William H., Clifford E. Douglas e Ross C. Brownson. "Chronic Disease Prevention". JAMA 316, n. 16 (25 ottobre 2016): 1645. http://dx.doi.org/10.1001/jama.2016.14370.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Pawar, Neha madhukar, e Archana Kulkarni. "CONCEPT OF VYADHIKSHAMATVA IN AYRVEDA". International Journal of Research -GRANTHAALAYAH 8, n. 8 (30 agosto 2020): 239–43. http://dx.doi.org/10.29121/granthaalayah.v8.i8.2020.1064.

Testo completo

Abstract (sommario):

For prevention of diseases, Ayurveda had advocated the adherence to concepts like dina charya, ritu charya, sadvritta , Na vega dharan etc. these measures are useful in preventing the lifestyle related diseases but for preventing the Aupsargik rogas (communicable diseases), Janapada dhwansa rogas (epidemic diseases), Krumij Roga (Infectious diseases), Asatmyaj roga (allergic disorders), the concept of Vyadhikshamtva (Immunity) is propagated by the Ayurvedic science [1]. According to the concept of Ojas or Vyadhikshamatva or Bala (immunity), the body‟s resistance is of tremendous importance in the daily welfare of living beings not only for disease prevention but also for rapid recovery after disease affliction. [2] Ayurveda propounds that prevention is an equally important aspect of disease management as cure and thus, strengthening the immune system, is a natural way to help the body fight against the disease-causing pathogens. Acharyas promoted the use of Rasayana (Rejuvenation) to enhance ojas and vyadhikshamatva (immunity). This article is an effort to present Ayurvedic concepts of Vyadhishamatva.

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Turner, Chris. "Prevention, prevention". Faculty Dental Journal 10, n. 3 (luglio 2019): 94–97. http://dx.doi.org/10.1308/rcsfdj.2019.94.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

21

O'g'li, Roxibjonov Adhamjon Raxmatjon. "PREVENTION OF DILATED CARDIOMYOPATHY DISEASE MEASURES TO TREAT IT". International Journal of Medical Sciences And Clinical Research 3, n. 12 (1 dicembre 2023): 13–18. http://dx.doi.org/10.37547/ijmscr/volume03issue12-03.

Testo completo

Abstract (sommario):

Dilated cardiomyopathy is myocardial dysfunction causing heart failure in which ventricular dilation and systolic dysfunction predominate. Symptoms include dyspnea, fatigue, and peripheral edema. Diagnosis is clinical and by elevated natriuretic peptides, chest x-ray, echocardiography, and MRI. Treatment is directed at the cause. If heart failure is progressive and severe, cardiac resynchronization therapy, implantable cardioverter-defibrillator, repair of moderate to severe valvular regurgitation, left ventricular assist device, or heart transplantation may be needed.

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Najmitdinovna, Kudratova Gulsara, e Ibragimova Yulduz Botyrovna. "PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN AND TEENAGERS". American Journal Of Biomedical Science & Pharmaceutical Innovation 4, n. 3 (1 marzo 2024): 52–55. http://dx.doi.org/10.37547/ajbspi/volume04issue03-07.

Testo completo

Abstract (sommario):

Bronchial asthma is considered a chronic disease and causes many health problems for the population. The disease is based on a genetic predisposition. Children whose parents have allergic diseases (bronchial asthma, allergic rhinitis, atopic dermatitis, eczema, Quincke's edema, etc.) have asthma in the first year of life the tendency to develop the disease is high. (25% if father or mother is sick with allergic diseases, 50% if allergic diseases are observed in both father and mother).

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Fugh-Berman, A., e S. Epstein. "Tamoxifen: disease prevention or disease substitution?" Lancet 340, n. 8828 (novembre 1992): 1143–45. http://dx.doi.org/10.1016/0140-6736(92)93161-f.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Berra, K., N. Houston Miller e J. M. Fair. "Cardiovascular Disease Prevention and Disease Management". Journal of Cardiopulmonary Rehabilitation 26, n. 4 (luglio 2006): 197–206. http://dx.doi.org/10.1097/00008483-200607000-00001.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Dmochowski, Tymon. "Green infrastructure as a disease prevention and rehabilitation tool". Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 28, n. 4 (29 dicembre 2019): 682–89. http://dx.doi.org/10.22630/pniks.2019.28.4.61.

Testo completo

Abstract (sommario):

This article tackles with the problem of preventing diseases caused by physical inactivity. It offers a brief review of deadliest diseases and defi nes critical role of green public spaces in their prevention. Article presents patient treatment costs, in contrast to the costs of organizing green public spaces, suggesting substantial relief from economic burden sustained by national health fund by offering green public spaces designed specifi cally for disease prevention instead of conventional treatment.

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Vakrilova Becheva, Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva e Valentina Boyanova Petkova. "Prevention of cardiovascular diseases". Pharmacia 70, n. 4 (27 ottobre 2023): 1243–47. http://dx.doi.org/10.3897/pharmacia.70.e114071.

Testo completo

Abstract (sommario):

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for patients with established cardiovascular disease and those at high risk include smoking cessation, healthy eating, physical activity, and lowering body mass index. There are various methods that are part of health promotion to reduce CVD risks. These methods include motivational interviewing, non-pharmacological means, the use of certain medications for CVD prevention, as well as physical activity. Strategies for effective primary prevention refer to engaging the patient to change their lifestyle and identifying risk factors, while secondary prevention is aimed at activities to detect the disease early and to slow down its progression. It is necessary to create a strategy for timely preventive actions with a view to preventing the negative influence of risk factors and improving people‘s heart health.

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Chew, Emily Y. "Disease Management by Prevention". Disease Management and Health Outcomes 6, n. 5 (1999): 279–90. http://dx.doi.org/10.2165/00115677-199906050-00005.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Traynor, Kate. "Disease prevention gains attention". American Journal of Health-System Pharmacy 66, n. 15 (1 agosto 2009): 1336–38. http://dx.doi.org/10.2146/news090063.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Lavie, Carl J., Ray W. Squires e Gerald T. Gau. "Prevention of cardiovascular disease". Postgraduate Medicine 81, n. 5 (aprile 1987): 52–72. http://dx.doi.org/10.1080/00325481.1987.11699780.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Tenenbaum, Ariel, Mohammed Morad e Joav Merrick. "Cardiovascular disease and prevention". International Journal of Adolescent Medicine and Health 26, n. 4 (1 novembre 2014): 457–58. http://dx.doi.org/10.1515/ijamh-2014-0004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Bauer, Michael, e Dominic Coppolo. "Agricultural Lung Disease: Prevention". Seminars in Respiratory and Critical Care Medicine 14, n. 01 (gennaio 1993): 83–89. http://dx.doi.org/10.1055/s-2007-1006311.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Coralli, Connie. "Disease Prevention/Health Promotion". Nurse Practitioner 15, n. 2 (febbraio 1990): 74. http://dx.doi.org/10.1097/00006205-199002000-00018.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Gardner, Pierce. "Prevention of Meningococcal Disease". New England Journal of Medicine 355, n. 14 (5 ottobre 2006): 1466–73. http://dx.doi.org/10.1056/nejmcp063561.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Kornhuber, J. "Prevention of Alzheimer's Disease". Fortschritte der Neurologie · Psychiatrie 73, n. 6 (giugno 2005): 315–16. http://dx.doi.org/10.1055/s-2004-830309.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Filley, Christopher M. "Alzheimer disease prevention: Table". Neurology: Clinical Practice 5, n. 3 (29 dicembre 2014): 193–200. http://dx.doi.org/10.1212/cpj.0000000000000108.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Zimmerman, Marcia. "Phytochemicals and Disease Prevention". Alternative and Complementary Therapies 1, n. 3 (aprile 1995): 154–57. http://dx.doi.org/10.1089/act.1995.1.154.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Szekely, C. A., J. C. S. Breitner e P. P. Zandi. "Prevention of Alzheimer's disease". International Review of Psychiatry 19, n. 6 (gennaio 2007): 693–706. http://dx.doi.org/10.1080/09540260701797944.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Thal, Leon J. "Prevention of Alzheimer Disease". Alzheimer Disease & Associated Disorders 20, Supplement 2 (luglio 2006): S97—S99. http://dx.doi.org/10.1097/00002093-200607001-00015.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Bloomgarden, Z. T. "Prevention of Cardiovascular Disease". Diabetes Care 30, n. 2 (26 gennaio 2007): 423–31. http://dx.doi.org/10.2337/dc07-zb02.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

&NA;. "Prevention of heart disease". Inpharma Weekly &NA;, n. 833 (aprile 1992): 3. http://dx.doi.org/10.2165/00128413-199208330-00004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

Paixao, Andre R. M., Colby R. Ayers, Jarett D. Berry, James A. de Lemos e Amit Khera. "Atherosclerotic Cardiovascular Disease Prevention". Circulation: Cardiovascular Quality and Outcomes 7, n. 5 (settembre 2014): 778–79. http://dx.doi.org/10.1161/circoutcomes.114.001139.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Holmes, Julia S., Irma E. Arispe e Ernest Moy. "Heart Disease and Prevention". Medical Care 43, Supplement (marzo 2005): I—33—I—41. http://dx.doi.org/10.1097/00005650-200503001-00006.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Porena, M., P. Guiggi e C. Micheli. "Prevention of Stone Disease". Urologia Internationalis 79, n. 1 (2007): 37–46. http://dx.doi.org/10.1159/000104440.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Couch, Patricia, e Gary E. Johnson. "Prevention of Lyme disease". American Journal of Health-System Pharmacy 49, n. 5 (1 maggio 1992): 1164–73. http://dx.doi.org/10.1093/ajhp/49.5.1164.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

King, Kathryn M., e Heather M. Arthur. "Coronary Heart Disease Prevention". Journal of Cardiovascular Nursing 18, n. 4 (settembre 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Hill, Martha N., e George A. Mensah. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 26, Supplement (luglio 2011): S4. http://dx.doi.org/10.1097/jcn.0b013e318213efe4.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Berra, Kathy, Barbara Fletcher, Laura L. Hayman e Nancy Houston Miller. "Global Cardiovascular Disease Prevention". Journal of Cardiovascular Nursing 28, n. 6 (2013): 505–13. http://dx.doi.org/10.1097/jcn.0b013e31826b6822.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Schafer, Tara E., e Steven M. Adair. "PREVENTION OF DENTAL DISEASE". Pediatric Clinics of North America 47, n. 5 (ottobre 2000): 1021–42. http://dx.doi.org/10.1016/s0031-3955(05)70256-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft e PatrickF James. "CORONARY HEART DISEASE PREVENTION". Lancet 332, n. 8619 (novembre 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Mccormick, JamesS, Petr Skrabanek, J. A. Lee e R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION". Lancet 332, n. 8621 (novembre 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Offriamo sconti su tutti i piani premium per gli autori le cui opere sono incluse in raccolte letterarie tematiche. Contattaci per ottenere un codice promozionale unico!